PALO ALTO, Calif., Jan. 4 /PRNewswire/ --
Connetics Corporation (Nasdaq: CNCT), a specialty pharmaceutical company
focused exclusively on the development and commercialization of dermatology
products, today announced that Thomas G. Wiggans, President and CEO, will
present at the JP Morgan H&Q 20th Annual Healthcare Conference on Wednesday,
January 9, 2002 beginning at 2:30 p.m. (PST), at The Westin St. Francis Hotel
in San Francisco.
Connetics' 30-minute presentation, including audio and slides, will be
webcast live over the Internet at http://www.connetics.com. The presentation also
will be archived for 30 days on the Company's Web site.
Connetics Corporation is an independent pharmaceutical company focused on
the development and commercialization of innovative therapeutics for the
dermatology market. The Company's marketed products are Luxiq(R)
(betamethasone valerate) Foam, 0.12% and OLUX(TM) (clobetasol propionate)
Foam, 0.05%. In April 2001, Connetics acquired Soltec Research Pty Ltd.
Soltec is focused on discovering and developing innovative topical drug
delivery formulations. These formulations aim to improve the management of
dermatological diseases, provide significant product differentiation, and
extend product life cycles. For more information about Connetics and its
products, please visit Connetics' Web Site at http://www.connetics.com, or send an
e-mail to ir@connetics.com.
SOURCE Connetics Corporation
 back to top
Related links:
http://www.connetics.com
CONTACT:
investor relations, Bruce Voss,
bvoss@lhai.com, or Martin Halsall, mhalsall@lhai.com, both of
Lippert/Heilshorn & Associates, +1-310-691-7100, for Connetics
Corporation; or John L. Higgins, Chief Financial Officer of
Connetics Corporation, +1-650-843-2800, or jhiggins@connetics.com
|
